Cutting-edge approach maps HIV's escape routes Fred Hutch scientists have constructed an atlas of mutations that HIV uses to escape broadly neutralizing antibodies, potent immune molecules that form our body’s first line of defense against the virus. The information could help guide researchers who are testing these antibodies’ potential to prevent or treat HIV infection, as well as those working to develop more effective preventive vaccines. Jan. 29, 2019
25 powerful years of HIV research For 25 years, Fred Hutch virologist Dr. Julie Overbaugh has helped lead the Mombasa Cohort, a unique group of women at high risk for HIV transmission. Feb. 26, 2018
Meet Global Oncology's deputy program head Dr. Thomas Uldrick brings expertise in HIV-related cancers and experience in — and a passion for — developing clinical trials to his new position at Fred Hutch Global Oncology. Feb. 22, 2018
Microbiome research refines HIV risk for women Drawing from data collected for years by AIDS researchers in six African nations, scientists have pinpointed seven bacterial species whose presence in high concentrations may significantly increase the risk of HIV infection in women. Jan. 25, 2018
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.